Oncoustics

Oncoustics is a Toronto-based medtech company that creates and deploys advanced, patented AI solutions for low-cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. The company's flagship OnX platform transforms inexpensive point-of-care ultrasound devices into powerful diagnostic tools capable of detecting and staging liver diseases such as fibrosis, steatosis, and inflammation in approximately five minutes at bedside. Founded from quantitative ultrasound research at the University of Toronto, Oncoustics has validated its technology across over 2,500 patients through international clinical partners and holds research agreements with leading hepatologists across North America.